A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis

NCT05382715 · clinicaltrials.gov ↗

TERMINATED

Status

175

Enrollment

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Colitis, Ulcerative

Interventions

DRUG: Ozanimod

Sponsor

Bristol-Myers Squibb